Literature DB >> 17401652

Inhibition of melatonin biosynthesis induces neurofilament hyperphosphorylation with activation of cyclin-dependent kinase 5.

Shaohui Wang1, Lingqiang Zhu, Hairong Shi, Hongyun Zheng, Qing Tian, Qun Wang, Rong Liu, Jian-Zhi Wang.   

Abstract

Decreased level of melatonin and hyperphosphorylation of neurofilament proteins have been reported in Alzheimer's disease (AD). However, the direct evidence linking melatonin and neurofilament phosphorylation is still lacking. Here, we investigated the effect of inhibiting melatonin biosynthesis on phosphorylation of neurofilament proteins and the involvement of cyclin-dependent kinase 5 (cdk-5) in rats. We observed that injection of haloperidol, a specific inhibitor of 5-hydroxyindole-O-methyltransferase, resulted in significantly decreased level of serum melatonin with a concomitantly increased phosphorylation of neurofilament proteins and activation of cdk-5 in rats. Exogenous supplementation of melatonin partially arrested the hyperphosphorylation of neurofilament and the activation of cdk-5. These results suggest that inhibition of melatonin biosynthesis may activate cdk-5 and thus induces Alzheimer-like hyperphosphorylation of neurofilament proteins.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17401652     DOI: 10.1007/s11064-007-9308-y

Source DB:  PubMed          Journal:  Neurochem Res        ISSN: 0364-3190            Impact factor:   3.996


  33 in total

Review 1.  Role of melatonin in Alzheimer-like neurodegeneration.

Authors:  Jian-zhi Wang; Ze-fen Wang
Journal:  Acta Pharmacol Sin       Date:  2006-01       Impact factor: 6.150

Review 2.  The pineal aging clock. Evidence, models, mechanisms, interventions.

Authors:  W Pierpaoli; V A Lesnikov
Journal:  Ann N Y Acad Sci       Date:  1994-05-31       Impact factor: 5.691

3.  Melatonin treatment stabilizes chronobiologic and cognitive symptoms in Alzheimer's disease.

Authors:  Luis I. Brusco; Miguel Márquez; Daniel P. Cardinali
Journal:  Neuro Endocrinol Lett       Date:  2000       Impact factor: 0.765

4.  Neurofilament protein levels in CSF are increased in dementia.

Authors:  L E Rosengren; J E Karlsson; M Sjögren; K Blennow; A Wallin
Journal:  Neurology       Date:  1999-03-23       Impact factor: 9.910

5.  Levels of nonphosphorylated and phosphorylated tau in cerebrospinal fluid of Alzheimer's disease patients : an ultrasensitive bienzyme-substrate-recycle enzyme-linked immunosorbent assay.

Authors:  Yuan Yuan Hu; Shan Shu He; Xiaochuan Wang; Qiu Hong Duan; Inge Grundke-Iqbal; Khalid Iqbal; Jianzhi Wang
Journal:  Am J Pathol       Date:  2002-04       Impact factor: 4.307

6.  Alzheimer-like phosphorylation of tau and neurofilament induced by cocaine in vivo.

Authors:  Shi-Jie Liu; Zheng-Yu Fang; Ying Yang; Heng-Mei Deng; Jian-Zhi Wang
Journal:  Acta Pharmacol Sin       Date:  2003-06       Impact factor: 6.150

7.  Modulation of phosphorylation of neuronal cytoskeletal proteins by neuronal depolarization.

Authors:  M Mata; P Honegger; D J Fink
Journal:  Cell Mol Neurobiol       Date:  1997-02       Impact factor: 5.046

8.  Scotophobin A causes dark avoidance in goldfish by elevating pineal N-acetylserotonin.

Authors:  N Satake; B E Morton
Journal:  Pharmacol Biochem Behav       Date:  1979-04       Impact factor: 3.533

9.  Decreased melatonin levels in postmortem cerebrospinal fluid in relation to aging, Alzheimer's disease, and apolipoprotein E-epsilon4/4 genotype.

Authors:  R Y Liu; J N Zhou; J van Heerikhuize; M A Hofman; D F Swaab
Journal:  J Clin Endocrinol Metab       Date:  1999-01       Impact factor: 5.958

Review 10.  Neurofilaments in health and disease.

Authors:  J P Julien; W E Mushynski
Journal:  Prog Nucleic Acid Res Mol Biol       Date:  1998
View more
  5 in total

1.  Activation of Glycogen Synthase Kinase-3 Mediates the Olfactory Deficit-Induced Hippocampal Impairments.

Authors:  Juan Hu; He-Zhou Huang; Xiang Wang; Ao-Ji Xie; Xiong Wang; Dan Liu; Jian-Zhi Wang; Ling-Qiang Zhu
Journal:  Mol Neurobiol       Date:  2014-11-05       Impact factor: 5.590

2.  Cnga2 Knockout Mice Display Alzheimer's-Like Behavior Abnormities and Pathological Changes.

Authors:  Ao-Ji Xie; En-Jie Liu; He-Zhou Huang; Yu Hu; Ke Li; Youming Lu; Jian-Zhi Wang; Ling-Qiang Zhu
Journal:  Mol Neurobiol       Date:  2015-09-16       Impact factor: 5.590

3.  Progress in the development of new drugs in Alzheimer's disease.

Authors:  Antoine Piau; F Nourhashémi; C Hein; C Caillaud; B Vellas
Journal:  J Nutr Health Aging       Date:  2011-01       Impact factor: 4.075

4.  Minocycline ameliorates D-galactose-induced memory deficits and loss of Arc/Arg3.1 expression.

Authors:  Xu Li; Fen Lu; Wei Li; Jun Xu; Xiao-Jing Sun; Ling-Zhi Qin; Qian-Lin Zhang; Yong Yao; Qing-Kai Yu; Xin-Liang Liang
Journal:  Mol Biol Rep       Date:  2016-08-06       Impact factor: 2.316

Review 5.  Mechanisms of Melatonin in Alleviating Alzheimer's Disease.

Authors:  Mayuri Shukla; Piyarat Govitrapong; Parichart Boontem; Russel J Reiter; Jutamaad Satayavivad
Journal:  Curr Neuropharmacol       Date:  2017       Impact factor: 7.363

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.